SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
Valuation | |
---|---|
Market Cap ($M) | 209.78 |
Enterprise Value ($M) | n/a |
Book Value ($M) | 15.20 |
Book Value / Share | 0.12 |
Price / Book | n/a |
NCAV ($M) | -6.30 |
NCAV / Share | -0.05 |
Price / NCAV | n/a |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -1.33 |
Return on Assets (ROA) | -0.67 |
Return on Equity (ROE) | n/a |
Liquidity (mrq) | |
---|---|
Quick Ratio | 1.48 |
Current Ratio | 1.48 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 20.67 |
Assets | 42.17 |
Liabilities | 26.97 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 6.35 |
Operating Income | -35.66 |
Net Income | -33.97 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -23.55 |
Cash from Investing | -3.21 |
Cash from Financing | 26.96 |
(click for more detail) |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Similar Companies | |
---|---|
TNGNQ – Tengion, Inc. | TQLB – Torque Lifestyle Brands, Inc. |
TRGM – Targeted Medical Pharma, Inc. | TRVN – Trevena, Inc. |
TSMRF – Tsumura & Co. |
Financial data and stock pages provided by
Fintel.io